APA (7th ed.) Citation

Du, Y., Guo, T., Hao, Y., Li, C., Tang, L., Li, X., . . . Xu, H. (2024). PKCδ serves as a potential biomarker and therapeutic target for microglia‐mediated neuroinflammation in Alzheimer's disease. Alzheimer's & dementia, 20(8), 5511-5527. https://doi.org/10.1002/alz.14047

Chicago Style (17th ed.) Citation

Du, Ying, et al. "PKCδ Serves as a Potential Biomarker and Therapeutic Target for Microglia‐mediated Neuroinflammation in Alzheimer's Disease." Alzheimer's & Dementia 20, no. 8 (2024): 5511-5527. https://doi.org/10.1002/alz.14047.

MLA (9th ed.) Citation

Du, Ying, et al. "PKCδ Serves as a Potential Biomarker and Therapeutic Target for Microglia‐mediated Neuroinflammation in Alzheimer's Disease." Alzheimer's & Dementia, vol. 20, no. 8, 2024, pp. 5511-5527, https://doi.org/10.1002/alz.14047.